SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Claris Lifesciences’ promoter sells 1.85% stake for Rs 23 crore

15 Apr 2013 Evaluate

Claris Lifesciences’ promoter Aditya Sushil Kumar Handa has sold around 12 lakh shares amounting to 1.85% stake for over Rs 23 crore. Handa has offloaded 11,80,120 shares on an average price of about Rs 200 per share in the company through open market transaction.

Meanwhile, Caduceus Capital 2 Mauritus has picked up 10.65 lakh shares in drug firm Claris Lifesciences for a little over Rs 21 crore.

At the end of January-March quarter, Handa held 33.71 lakh shares or 5.28% stake in Claris Lifesciences, while Caduceus Capital Master Mauritius Ltd held 7.50 lakh scrips or 1.18% holding in the drug firm.

Claris Lifesciences is one of the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Their product offering comprises of 113 products across multiple markets and therapeutic areas.

Peers
Company Name CMP
Redington 220.70
Adani Enterprises 2300.50
Amrapali Industries 17.45
Rashi Peripheral 475.55
PDS 285.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×